GOL Linhas Aereas Inteligentes S.A. (NYSE:GOL) represented a move of 3.44 percent or $-0.3 per share and closed its previous day trading session at $10.82. 522828 Shares were traded in the last trading session with an Average Volume of 367.09 Million Shares. The stock currently has a Market Capitalization of 1.48 Billion.
GOL Linhas Aereas Inteligentes is a low-cost, low-fare airline.
The stock traded between $ 4.13 and $11.81 over 1-Year time period showing its price to sales ratio of 0.47. GOL Linhas Aereas Inteligentes S.A. (NYSE:GOL) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $12.86 and 200-Day Simple Moving Average of $42.66. Its Price to Free Cash Flow is 3.3 and Price to Book of 0.
Analyst’s recommended the stock as 2.6 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, GOL Linhas Aereas Inteligentes S.A. (NYSE:GOL) reported its Actual EPS of $0.6/share. The analysts offering Earnings Estimates for the company were believing that GOL Linhas Aereas Inteligentes S.A. could bring EPS of $0.21/share. The difference between Actual EPS and Estimated EPS was 0.39 Percent. Thus showing an Earnings Surprise of 185.7 Percent.
Cambrex Corporation (NYSE:CBM)
In the last trading session, Cambrex Corporation (NYSE:CBM) added its value by -2.64% closing at the price of $53.5. The stock currently has market capitalization of 1.76 Billion, with average volume of 374.08 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Cambrex Corporation (NYSE:CBM) is showing beta of 2.2. This particular value of beta suggests that Cambrex Corporation (NYSE:CBM) has historically moved 220% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Cambrex Corporation (NYSE:CBM) is at $3.05.
The stock currently has RSI of 50.59. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Cambrex Corporation is an innovative life sciences company with a refreshingly human approach. Driven by passion, their pharmaceutical products, expertise and technologies accelerate customers’ small molecule therapeutics into markets across the world. The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances. Cambrex has transformed from a fine chemical manufacturer to a business with a singular focus on small molecule therapeutics.
Cambrex Corporation (NYSE:CBM) topped its 52-week high price of $62.95 on 05/04/17 and 52-Week Low Price of $42.55 on 11/06/17. The Stock currently has P/E (price to earnings ttm) of 17.56 and Weekly volatility of 5.28% and monthly volatility of 3.30% respectively.